Skip to main content
OpenTrials
Completed

NCT Number: NCT04361864

Cross-sectional Survey on Patients With Urinary Tract Infections in Puy-de-Dôme : Epidemiology of Recurrent Urinary Tract Infections and Risk Factors

Urinary tract infections (UTI) are an important part of infectious diseases. For some patients, those infections are recurrent and have many consequences such as altered quality of life, recurrent symptoms, antibiotics overuse… The primary purpose of this study is to estimate the proportion of patients in Puy-de-Dôme with recurrent urinary tract infections among patients with at least one UTI during 2019. The secondary purposes are : characteristics of patients with recurrent UTI, by sex ; determine predictive factors of recurrent UTI, by sex ; describe bacterial ecology of recurrent UTI and the proportion of multi-resistant bacteria.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Urinary Tract Infections Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Infections Male Urogenital Diseases Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chu Clermont Ferrand

Clermont-Ferrand, 63003, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patient from 18 years old
  • affiliated to the french healthcare system
  • with at least one urinary tract infection during year 2019
  • has accepted email contact with CPAM 63 (Caisse Primaire d'Assurance Maladie du Puy-de-Dôme)

Exclusion criteria

  • pregnancy during year 2019
  • none urinary tract infection reported in 2019

Treatment and study plan

Primary outcomes

  1. Proportion of recurrent urinary tract infections

    Time frame: During year 2019

    Proportion, with its 95% confidence interval, of recurrent urinary tract infections, by sex, in the population of Puy-de-Dôme who reported having had at least one urinary tract infection in the year 2019.

    The diagnosis of recurrent urinary tract infection will be at least 3 urinary tract infections in one year

Secondary outcomes

  1. age in year

    Time frame: day 1

    Risk factors of recurrent urinary tract infections

  2. sexe

    Time frame: day 1

    Risk factors of recurrent urinary tract infections

  3. , medical and surgical history

    Time frame: day 1

    Risk factors of recurrent urinary tract infections

  4. life habits

    Time frame: day 1

    Risk factors of recurrent urinary tract infections

  5. number of visits at the general practitioner

    Time frame: during year 2019

    measure of healthcare consumption with the number of visits at the general practitioner performed

  6. number of urinalysis

    Time frame: during year 2019

    measure of healthcare consumption with the number of urinalysis performed

  7. number of antibiotic therapies

    Time frame: during year 2019

    measure of healthcare consumption with the number of antibiotic therapies performed

  8. quality of life

    Time frame: during year 2019

    quality of life evaluated with a self-reported questionnaire inspired by the Leicester Impact Scale

  9. bacteriological characteristics of recurrent urinary tract infections

    Time frame: during year 2019

    evaluated with results of urinalysis, bacterial identification and antimicrobial susceptibility

Sponsors and collaborators

Lead sponsor

University Hospital, Clermont-Ferrand

Other

Collaborators

  • Caisse Primaire d'Assurance Maladie du Puy-de-Dôme

Registry information

Acronym: IUR63

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Apr 24, 2020
Registry last updated
May 7, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.